Growth opportunity UreSil is experiencing record growth in the Interventional Radiology and Vascular Surgery markets, signaling strong demand for innovative devices and potential expansion through new partnerships and distribution agreements.

Partnership potential The company actively seeks collaborations with other device manufacturers and physicians, presenting multiple avenues for co-development, white-labeling, or strategic alliances to accelerate market penetration.

Quality focus With a commitment that every device improves care for clinicians, patients, and supply chains, UreSil positions as a value-added partner for hospitals and distributors prioritizing efficacy, safety, and throughput.

Financial scale Current revenue range ($1M–$10M) and mid-size employee base indicate a nimble organization with growth potential suitable for scalable partnerships, pilot programs, or performance-based collaboration models.

Tech and reach A tech-forward profile using modern web technologies and a focus on interventional radiology and vascular surgery suggests opportunities to integrate with existing device ecosystems, preclinical workflows, and post-market support platforms.